Institution: Basilea Pharmaceutica
Address:
Basilea Pharmaceutica International Ltd. Grenzacherstrasse 487 PO Box 4005 Basel Switzerland
Email: diana.otto@basilea.com
Group website: www.basilea.com
Phone: +41 61 606 1365
Research interests:
Cancer Biology Drug discovery and development
Selected publications:
Note publications under maiden name: Diana Perez-Madrigal 1) ERK5 is a critical mediator of inflammation-driven cancer. Finegan KG, Perez-Madrigal D, Hitchin JR, Davies CC, Jordan AM, Tournier C. Cancer Res. 2015 Feb 15;75(4):742-53. 2) The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs).Perez-Madrigal D, Finegan KG, Paramo B, Tournier C. Cell Signal. 2012 Dec;24(12):2360-8
